Last reviewed · How we verify
NCT03346889: VOVS
Vestibular Outcomes in Vestibular Schwannoma
trial in Vestibular Schwannoma in 155 participants. Participants enrolled and being followed up; not accepting new ones.
25 June 2019
Quick facts
| Lead sponsor | Haukeland University Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 155 |
| Start date | 23 April 2017 |
| Primary completion | 25 June 2019 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Norway |
Conditions studied
- Vestibular Schwannoma — all drugs for Vestibular Schwannoma →
Sponsor
Haukeland University Hospital
Who can join
Eligibility, any sex, with Vestibular Schwannoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Previous studies have shown that vertigo is the symptoms that mostly affect quality of life in patients with vestibular schwannoma. There is still limited knowledge as to why some patients with this disorder develop vertigo, while others with the same diagnosis do not. The purpose of this study is to measure symptom-related quality of life and to relate this to objective disease characteristics at baseline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03346889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vestibular Schwannoma
Currently open trials in the same condition.
- NCT07364955 — Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma · NA · recruiting
- NCT07130851 — Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma · NA · active not recruiting
- NCT06572475 — USPIO Enhanced MR Imaging in CNS Tumours (UMIC) · NA · recruiting
- NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting
- NCT05641441 — Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma · recruiting
Other Haukeland University Hospital trials
Trials by the same sponsor.
- NCT07450105 — Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study · NA · not yet recruiting
- NCT07450092 — Prehospital Use of Forced Air Warming · NA · enrolling by invitation
- NCT07268716 — Assess the Efficacy of Tailored Patient Information and Voluntary Patient-managed Outpatient Digital Follow-up (I-POD) a · NA · not yet recruiting
- NCT07392697 — The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease · NA · not yet recruiting
- NCT07304219 — Physical Activity Based Treatment for Youth With Depression and Anxiety · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03346889 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Haukeland University Hospital
- Last refreshed: 30 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03346889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing